Mylan Gmbh`s Biologic Ogivri Receives Suppl Approval in US
13 Nov 2024 //
FDA
Department of Justice No Longer Considers Mylan Subject Of Antitrust
02 Jul 2024 //
PR NEWSWIRE
Mylan`s Generic Epoprostenol Sodium Receives Approval in US
12 Jun 2024 //
FDA
Viatris leans in on brand drug portfolio for future growth
08 May 2023 //
ENDPTS